{"transactions":[{"id":307414,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14435,"kind":"person","name":"McKechnie Duncan","position":1,"cik":"0002062139","reported_name":"McKechnie Duncan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-07-07T20:08:03.000Z","date":"2026-07-02","kind":"sale","planned":true,"acquired":false,"shares":1541,"price":519,"value":799779.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. McKechnie's company approved trading plan under Rule 10b5-1, which was entered into on 11/25/2025."}],"balance_after":11001,"source":{"system":"sec-edgar","filing":"0000875320-26-000243","document":"wk-form4_1783454880.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000243/wk-form4_1783454880.xml","form_type":"4"}},{"id":311581,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14435,"kind":"person","name":"McKechnie Duncan","position":1,"cik":"0002062139","reported_name":"McKechnie Duncan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-13T20:11:50.000Z","date":"2026-03-11","kind":"sale","planned":true,"acquired":false,"shares":2633,"price":498.42,"value":1312339.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. McKechnie's company approved trading plan under Rule 10b5-1, which was entered into on 11/25/2025."}],"balance_after":12489,"source":{"system":"sec-edgar","filing":"0000875320-26-000138","document":"wk-form4_1773432707.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000138/wk-form4_1773432707.xml","form_type":"4"}},{"id":311990,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14435,"kind":"person","name":"McKechnie Duncan","position":1,"cik":"0002062139","reported_name":"McKechnie Duncan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-06T21:05:56.000Z","date":"2026-03-04","kind":"sale","planned":true,"acquired":false,"shares":2437,"price":475.3,"value":1158306.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. McKechnie's company approved trading plan under Rule 10b5-1, which was entered into on 11/25/2025."}],"balance_after":15122,"source":{"system":"sec-edgar","filing":"0000875320-26-000136","document":"wk-form4_1772831152.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000136/wk-form4_1772831152.xml","form_type":"4"}},{"id":312730,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14435,"kind":"person","name":"McKechnie Duncan","position":1,"cik":"0002062139","reported_name":"McKechnie Duncan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-26T23:48:22.000Z","date":"2026-02-25","kind":"sale","planned":true,"acquired":false,"shares":2410,"price":489,"value":1178490.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. McKechnie's company approved trading plan under Rule 10b5-1, which was entered into on 11/25/2025."}],"balance_after":17559,"source":{"system":"sec-edgar","filing":"0000875320-26-000116","document":"wk-form4_1772149699.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000116/wk-form4_1772149699.xml","form_type":"4"}},{"id":312729,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14435,"kind":"person","name":"McKechnie Duncan","position":1,"cik":"0002062139","reported_name":"McKechnie Duncan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-26T23:48:22.000Z","date":"2026-02-25","kind":"sale","planned":true,"acquired":false,"shares":2500,"price":486.35,"value":1215875.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. McKechnie's company approved trading plan under Rule 10b5-1, which was entered into on 11/25/2025."}],"balance_after":19969,"source":{"system":"sec-edgar","filing":"0000875320-26-000116","document":"wk-form4_1772149699.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000116/wk-form4_1772149699.xml","form_type":"4"}},{"id":312728,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14435,"kind":"person","name":"McKechnie Duncan","position":1,"cik":"0002062139","reported_name":"McKechnie Duncan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-26T23:48:22.000Z","date":"2026-02-24","kind":"tax_withholding","planned":true,"acquired":false,"shares":873,"price":485.11,"value":423501.03,"ownership":{"direct":true},"balance_after":22469,"source":{"system":"sec-edgar","filing":"0000875320-26-000116","document":"wk-form4_1772149699.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000116/wk-form4_1772149699.xml","form_type":"4"}},{"id":313135,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14435,"kind":"person","name":"McKechnie Duncan","position":1,"cik":"0002062139","reported_name":"McKechnie Duncan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-19T21:21:12.000Z","date":"2026-02-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":1148,"price":483.75,"value":555345.0,"ownership":{"direct":true},"balance_after":23342,"source":{"system":"sec-edgar","filing":"0000875320-26-000094","document":"wk-form4_1771536070.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000094/wk-form4_1771536070.xml","form_type":"4"}},{"id":313134,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14435,"kind":"person","name":"McKechnie Duncan","position":1,"cik":"0002062139","reported_name":"McKechnie Duncan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-19T21:21:12.000Z","date":"2026-02-17","kind":"grant","planned":false,"acquired":true,"shares":4962,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award that vests in installments beginning on February 20, 2027."}],"balance_after":24490,"source":{"system":"sec-edgar","filing":"0000875320-26-000094","document":"wk-form4_1771536070.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000094/wk-form4_1771536070.xml","form_type":"4"}},{"id":313474,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14435,"kind":"person","name":"McKechnie Duncan","position":1,"cik":"0002062139","reported_name":"McKechnie Duncan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-18T21:37:50.000Z","date":"2026-02-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":2283,"price":487.76,"value":1113556.08,"ownership":{"direct":true},"balance_after":19528,"source":{"system":"sec-edgar","filing":"0000875320-26-000072","document":"wk-form4_1771450668.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000072/wk-form4_1771450668.xml","form_type":"4"}},{"id":313861,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14435,"kind":"person","name":"McKechnie Duncan","position":1,"cik":"0002062139","reported_name":"McKechnie Duncan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-12T22:04:15.000Z","date":"2026-02-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1127,"price":468.41,"value":527898.07,"ownership":{"direct":true},"balance_after":21811,"source":{"system":"sec-edgar","filing":"0000875320-26-000048","document":"wk-form4_1770933853.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000048/wk-form4_1770933853.xml","form_type":"4"}},{"id":314829,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14435,"kind":"person","name":"McKechnie Duncan","position":1,"cik":"0002062139","reported_name":"McKechnie Duncan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-01-26T21:30:15.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":2080,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents earned performance shares with respect to a performance stock unit award granted on 02/12/2025 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 01/22/2026 and the shares will vest in installments beginning on 02/24/2026."}],"balance_after":22938,"source":{"system":"sec-edgar","filing":"0000875320-26-000022","document":"wk-form4_1769463011.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000022/wk-form4_1769463011.xml","form_type":"4"}},{"id":314828,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14435,"kind":"person","name":"McKechnie Duncan","position":1,"cik":"0002062139","reported_name":"McKechnie Duncan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-01-26T21:30:15.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":4720,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents earned performance shares with respect to a performance stock unit award granted on 02/01/2023 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 01/22/2026 and the shares will vest on 02/13/2026."}],"balance_after":20858,"source":{"system":"sec-edgar","filing":"0000875320-26-000022","document":"wk-form4_1769463011.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000022/wk-form4_1769463011.xml","form_type":"4"}}]}